Word has it Roche may outbid Abt for DEPO. Roche really wants the new delivery technology for application to its other pain meds, which can impact patent extensions under the new technology. Things will get interesting... Hold on to your shares!
It's probably easier handicapping the next super bowl winner than who would win the Gralise sweepstakes. Gralise is the best in class medicine for several indications. Believe me, there are several bidding and Depomed will not settle.